scispace - formally typeset
C

Carlo Lavia

Researcher at University of Turin

Publications -  24
Citations -  1440

Carlo Lavia is an academic researcher from University of Turin. The author has contributed to research in topics: Glaucoma & Medicine. The author has an hindex of 16, co-authored 21 publications receiving 1090 citations. Previous affiliations of Carlo Lavia include Paris Diderot University.

Papers
More filters
Journal ArticleDOI

Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis.

TL;DR: Although MIGS seem efficient in the reduction of the IOP and glaucoma medication and show good safety profile, this evidence is mainly derived from non-comparative studies and further, good quality RCTs are warranted.
Journal ArticleDOI

Microperimetric Assessment after Epiretinal Membrane Surgery: 4-Year Follow-Up

TL;DR: Long-term follow-up using microperimetry seems useful to evaluate patients after iERM surgery: retinal sensitivity changes even when BCVA and CRT remain stable.
Journal ArticleDOI

Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma

Chiea Chuen Khor, +251 more
- 01 May 2016 - 
TL;DR: It is confirmed that significant association at three previously described loci (P < 5 × 10−8 for each sentinel SNP at PLEKHA7, COL11A1, and PCMTD1–ST18), providing new insights into the biology of PACG, is confirmed.
Journal ArticleDOI

Keraring Intrastromal Segment Depth Measured by Spectral-Domain Optical Coherence Tomography in Eyes with Keratoconus

TL;DR: The distance of the inner corner from the posterior corneal surface showed the best agreement with the intended distance, suitable for determining whether the actual Keraring depth matches the intended depth.
Journal ArticleDOI

Genetic association study of exfoliation syndrome identifies a protective rare variant at LOXL1 and five new susceptibility loci

Tin Aung, +315 more
- 29 May 2017 - 
TL;DR: A rare protective allele at LOXL1 is identified through deep resequencing of XFS cases and controls and a potential role for naturally occurring rare LO XL1 variants in disease biology is highlighted.